- Home
- ATIP vs COCP Comparison
ATIP vs COCP Comparison
Compare ATIP & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATIP
- COCP
- Stock Information
- Founded
- ATIP 1996
- COCP N/A
- Country
- ATIP United States
- COCP United States
- Employees
- ATIP N/A
- COCP N/A
- Industry
- ATIP Hospital/Nursing Management
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- ATIP Health Care
- COCP Health Care
- Exchange
- ATIP Nasdaq
- COCP Nasdaq
- Market Cap
- ATIP 26.0M
- COCP 18.2M
- IPO Year
- ATIP N/A
- COCP N/A
- Fundamental
- Price
- ATIP $6.24
- COCP $2.04
- Analyst Decision
- ATIP
- COCP Strong Buy
- Analyst Count
- ATIP 0
- COCP 1
- Target Price
- ATIP N/A
- COCP $7.00
- AVG Volume (30 Days)
- ATIP 7.9K
- COCP 18.6K
- Earning Date
- ATIP 11-04-2024
- COCP 11-11-2024
- Dividend Yield
- ATIP N/A
- COCP N/A
- EPS Growth
- ATIP N/A
- COCP N/A
- EPS
- ATIP N/A
- COCP N/A
- Revenue
- ATIP $717,149,000.00
- COCP N/A
- Revenue This Year
- ATIP $10.99
- COCP N/A
- Revenue Next Year
- ATIP $5.98
- COCP N/A
- P/E Ratio
- ATIP N/A
- COCP N/A
- Revenue Growth
- ATIP 11.00
- COCP N/A
- 52 Week Low
- ATIP $3.92
- COCP $1.33
- 52 Week High
- ATIP $8.48
- COCP $3.10
- Technical
- Relative Strength Index (RSI)
- ATIP 60.27
- COCP 61.73
- Support Level
- ATIP $5.66
- COCP $1.66
- Resistance Level
- ATIP $6.46
- COCP $1.87
- Average True Range (ATR)
- ATIP 0.30
- COCP 0.15
- MACD
- ATIP 0.01
- COCP 0.04
- Stochastic Oscillator
- ATIP 72.50
- COCP 48.10
About ATIP ATI Physical Therapy Inc.
ATI Physical Therapy Inc is a recognized outpatient physical therapy provider in the United States specializing in outpatient rehabilitation and adjacent healthcare services. It offer a variety of services within the clinics, including physical therapy to treat spine, shoulder, knee and neck injuries or pain; work injury rehabilitation services, including work conditioning and work hardening; hand therapy; and other specialized treatment services.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).